Your browser doesn't support javascript.
loading
Improved overall survival in patients with high-grade serous ovarian cancer is associated with CD16a+ immunologic neighborhoods containing NK cells, T cells and macrophages.
Nersesian, Sarah; Arseneau, Riley J; Mejia, Jorge P; Lee, Stacey N; Westhaver, Lauren P; Griffiths, Nigel W; Grantham, Stephanie R; Meunier, Liliane; Communal, Laudine; Mukherjee, Avik; Mes-Masson, Anne-Marie; Arnason, Thomas; Nelson, Brad H; Boudreau, Jeanette E.
  • Nersesian S; Department of Microbiology and Immunology, Dalhousie University, Halifax, NS, Canada.
  • Arseneau RJ; Beatrice Hunter Cancer Research Institute, Halifax, NS, Canada.
  • Mejia JP; Beatrice Hunter Cancer Research Institute, Halifax, NS, Canada.
  • Lee SN; Department of Pathology, Dalhousie University, Halifax, NS, Canada.
  • Westhaver LP; Department of Microbiology and Immunology, Dalhousie University, Halifax, NS, Canada.
  • Griffiths NW; Beatrice Hunter Cancer Research Institute, Halifax, NS, Canada.
  • Grantham SR; Department of Microbiology and Immunology, Dalhousie University, Halifax, NS, Canada.
  • Meunier L; Beatrice Hunter Cancer Research Institute, Halifax, NS, Canada.
  • Communal L; Department of Pathology, Dalhousie University, Halifax, NS, Canada.
  • Mukherjee A; Department of Pathology, Dalhousie University, Halifax, NS, Canada.
  • Mes-Masson AM; Beatrice Hunter Cancer Research Institute, Halifax, NS, Canada.
  • Arnason T; Centre de recherche du Centre hospitalier de l'Université de Montréal and Institut du cancer de Montréal, Montreal, QC, Canada.
  • Nelson BH; Centre de recherche du Centre hospitalier de l'Université de Montréal and Institut du cancer de Montréal, Montreal, QC, Canada.
  • Boudreau JE; Akoya Biosciences, Menlo Park, CA, United States.
Front Immunol ; 14: 1307873, 2023.
Article en En | MEDLINE | ID: mdl-38318505
ABSTRACT

Background:

For patients with high grade serous carcinoma of the ovary (HGSC), survival rates have remained static for the last half century. Despite the presence of tumor mutations and infiltration of immune cells, existing immunotherapies have achieved little success against HGSC. These observations highlight a gap in the understanding of how the immune system functions and interacts within HGSC tumors.

Methods:

We analyzed duplicate core samples from 939 patients with HGSC to understand patterns of immune cell infiltration, localization, and associations with clinical features. We used high-parameter immunohistochemical/Opal multiplex, digital pathology, computational biology, and multivariate analysis to identify immune cell subsets and their associations with HGSC tumors.

Results:

We defined six patterns of cellular infiltration by spatially restricted unsupervised clustering of cell subsets. Each pattern was represented to some extent in most patient samples, but their specific distributions differed. Overall (OS) and progression-free survival (PFS) corresponded with higher infiltration of CD16a+ cells, and their co-localization with macrophages, T cells, NK cells, in one of six cellular neighborhoods that we defined with our spatial assessment.

Conclusions:

Immune cell neighborhoods containing CD16a+ cells are associated with improved OS and PFS for patients with HGSC. Patterns of immunologic neighborhoods differentiate patient outcomes, and could inform future, more precise approaches to treatment.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Cistadenocarcinoma Seroso Tipo de estudio: Risk_factors_studies Límite: Female / Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Cistadenocarcinoma Seroso Tipo de estudio: Risk_factors_studies Límite: Female / Humans Idioma: En Año: 2023 Tipo del documento: Article